Header cover image

U.S. Life Sciences Industry Analysis

UpdatedNov 30, 2022
DataAggregated Company Financials
Companies76
  • 7D-1.7%
  • 3M-1.1%
  • 1Y-29.7%
  • YTD-26.1%

Over the last 7 days, the Life Sciences industry has dropped 1.7%, and Danaher contributed the most with a 1.2% decline. Overall the industry is down 30% in 12 months. Earnings are forecast to grow by 14% annually.

Industry Valuation and Performance

Has the U.S. Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 30 Nov 2022US$747.9bUS$155.1bUS$8.8b28.1x85.2x4.8x
Fri, 28 Oct 2022US$714.1bUS$154.5bUS$17.0b26.6x41.9x4.6x
Sun, 25 Sep 2022US$713.9bUS$152.2bUS$17.3b25.5x41.3x4.7x
Tue, 23 Aug 2022US$800.2bUS$152.2bUS$17.3b30.6x46.2x5.3x
Thu, 21 Jul 2022US$754.8bUS$148.1bUS$20.1b31x37.6x5.1x
Sat, 18 Jun 2022US$678.3bUS$148.1bUS$20.1b27.5x33.7x4.6x
Mon, 16 May 2022US$726.4bUS$148.0bUS$20.0b30.4x36.2x4.9x
Wed, 13 Apr 2022US$845.2bUS$146.5bUS$25.3b36x33.4x5.8x
Fri, 11 Mar 2022US$819.3bUS$146.2bUS$25.3b35.3x32.4x5.6x
Sun, 06 Feb 2022US$862.7bUS$139.8bUS$26.9b40.3x32.1x6.2x
Tue, 04 Jan 2022US$969.3bUS$138.0bUS$27.3b44.1x35.5x7x
Thu, 02 Dec 2021US$960.6bUS$138.0bUS$27.3b44.3x35.2x7x
Sat, 30 Oct 2021US$754.1bUS$107.8bUS$21.5b48.3x35.1x7x
Mon, 27 Sep 2021US$766.7bUS$105.9bUS$18.6b53.1x41.1x7.2x
Wed, 25 Aug 2021US$730.3bUS$105.8bUS$18.7b51.9x39.1x6.9x
Thu, 01 Jul 2021US$656.3bUS$101.0bUS$17.6b39.3x37.2x6.5x
Sun, 04 Apr 2021US$569.5bUS$92.3bUS$15.4b38.8x37x6.2x
Wed, 06 Jan 2021US$553.9bUS$89.0bUS$14.2b39x39x6.2x
Sat, 10 Oct 2020US$450.0bUS$79.8bUS$11.8b38.6x38.2x5.6x
Fri, 03 Jul 2020US$388.7bUS$77.1bUS$8.8b38.4x44x5x
Mon, 06 Apr 2020US$302.9bUS$77.3bUS$8.5b30.2x35.5x3.9x
Thu, 09 Jan 2020US$360.7bUS$76.7bUS$8.9b35.2x40.4x4.7x
Price to Earnings Ratio

49.4x


Total Market Cap: US$346.8bTotal Earnings: US$7.0bTotal Revenue: US$75.6bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Life Sciences Industry Price to Earnings3Y Average 40.3x202020212022
Current Industry PE
  • Investors are optimistic on the American Life Sciences industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 85.2x which is higher than its 3-year average PE of 40.3x.
  • The 3-year average PS ratio of 5.7x is higher than the industry's current PS ratio of 4.8x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have grown 7.7% per year over the last three years.
  • Revenues for these companies have grown 27% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare industry?

US Market-0.94%
Healthcare-0.045%
Life Sciences-1.67%
Clinical Research and Equipment-1.67%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AVTR AvantorUS$21.311.1%
+US$161.8m
-46.0%PE24x
STVN Stevanato GroupUS$15.253.5%
+US$135.0m
-36.1%PE28.1x
QGEN QiagenUS$48.881.2%
+US$132.1m
-11.3%PE22.8x
CYRX CryoportUS$18.463.6%
+US$31.4m
-72.2%PS3.9x
SYNH Syneos HealthUS$33.820.8%
+US$27.8m
-65.2%PE12.1x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

A

US$150.94

Agilent Technologies

7D

-3.8%

1Y

0.03%

MTD

US$1,412.21

Mettler-Toledo International

7D

-1.9%

1Y

-6.7%

BRKR

US$65.14

Bruker

7D

-4.6%

1Y

-19.6%

QGEN

US$48.88

Qiagen

7D

1.2%

1Y

-11.3%

TMO

US$539.75

Thermo Fisher Scientific

7D

-0.9%

1Y

-14.7%

AZTA

US$57.25

Azenta

7D

-0.4%

1Y

-49.4%

AVTR

US$21.31

Avantor

7D

1.1%

1Y

-46.0%

MEDP

US$207.24

Medpace Holdings

7D

-6.5%

1Y

-0.08%

CGEN

US$1.03

Compugen

7D

11.9%

1Y

-76.7%

ILMN

US$208.57

Illumina

7D

-6.1%

1Y

-42.9%

QTRX

US$12.70

Quanterix

7D

5.5%

1Y

-68.2%

CYRX

US$18.46

Cryoport

7D

3.6%

1Y

-72.2%

STVN

US$15.25

Stevanato Group

7D

3.5%

1Y

-36.1%